ScoreWhy is Youngy Health Co., Ltd. ?
1
Poor Management Efficiency with a low ROCE of 6.86%
- The company has been able to generate a Return on Capital Employed (avg) of 6.86% signifying low profitability per unit of total capital (equity and debt)
2
Poor long term growth as Net Sales has grown by an annual rate of 11.22% and Operating profit at 34.77% over the last 5 years
3
Flat results in Mar 26
- NET PROFIT(HY) At CNY 32.57 MM has Grown at -22.55%
4
With ROE of 8.68%, it has a fair valuation with a 2.17 Price to Book Value
- Over the past year, while the stock has generated a return of 5.32%, its profits have risen by 28.1% ; the PEG ratio of the company is 0.9
5
Underperformed the market in the last 1 year
- The stock has generated a return of 5.32% in the last 1 year, much lower than market (China Shanghai Composite) returns of 20.18%
Real-Time Research ReportHow much should you hold?
- Overall Portfolio exposure to Youngy Health Co., Ltd. should be less than 10%
- Overall Portfolio exposure to Tour, Travel Related Services should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Tour, Travel Related Services)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is Youngy Health Co., Ltd. for you?
High Risk, High Return
Absolute
Risk Adjusted
Volatility
Youngy Health Co., Ltd.
-3.08%
1.33
42.13%
China Shanghai Composite
19.22%
1.46
13.80%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
11.22%
EBIT Growth (5y)
34.77%
EBIT to Interest (avg)
33.28
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.57
Sales to Capital Employed (avg)
0.66
Tax Ratio
25.24%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
6.86%
ROE (avg)
5.32%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
25
Industry P/E
Price to Book Value
2.17
EV to EBIT
14.17
EV to EBITDA
12.20
EV to Capital Employed
3.41
EV to Sales
2.08
PEG Ratio
0.89
Dividend Yield
NA
ROCE (Latest)
24.04%
ROE (Latest)
8.68%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Mildly Bearish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
No Trend
No Trend
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend4What is working for the Company
NET SALES(9M)
At CNY 740.25 MM has Grown at 21.95%
RAW MATERIAL COST(Y)
Fallen by -7.58% (YoY
CASH AND EQV(HY)
Highest at CNY 1,383.23 MM
-2What is not working for the Company
NET PROFIT(HY)
At CNY 32.57 MM has Grown at -22.55%
Here's what is working for Youngy Health Co., Ltd.
Net Sales
At CNY 740.25 MM has Grown at 21.95%
Year on Year (YoY)MOJO Watch
Near term sales trend is positive
Net Sales (CNY MM)
Cash and Eqv
Highest at CNY 1,383.23 MM
in the last six Semi-Annual periodsMOJO Watch
Short Term liquidity is improving
Cash and Cash Equivalents
Raw Material Cost
Fallen by -7.58% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Here's what is not working for Youngy Health Co., Ltd.
Net Profit
At CNY 32.57 MM has Grown at -22.55%
Year on Year (YoY)MOJO Watch
Near term Net Profit trend is negative
Net Profit (CNY MM)
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
